IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding IDEAYA Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 112 | 1 | 117 | +6 |
| Shares | 44.7M | 447 | 46.0M | +1.24M (+2.8%) |
| Value | $667.1M | $7.00K | $835.0M | +$167.8M (+25.2%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 186,427 | $3.39M | 0.00% |
| Norges Bank | 137,500 | $2.50M | 0.00% |
| Nordea Investment Management AB | 62,325 | $1.13M | 0.00% |
| State of Wisconsin Investment Board | 37,596 | $683.1K | 0.00% |
| Acadian Asset Management LLC | 25,464 | $461.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 20,941 | $380.5K | 0.00% |
| Jane Street Group, LLC | 13,686 | $248.7K | 0.00% |
| American Century Companies Inc | 11,912 | $216.4K | 0.00% |
| ExodusPoint Capital Management, LP | 10,950 | $199.0K | 0.00% |
| Arizona State Retirement System | 10,850 | $197.1K | 0.00% |
| Principal Financial Group Inc | 10,438 | $189.7K | 0.00% |
| Lazard Asset Management LLC | 3,502 | $63.0K | 0.00% |
| Point72 Asset Management, L.P. | 2,681 | $48.7K | 0.00% |
| High Net Worth Advisory Group LLC | 1,500 | $27.3K | 0.01% |
| Steward Partners Investment Advisory, LLC | 250 | $4.54K | 0.00% |
| Allworth Financial LP | 67 | $1.22K | 0.00% |
| Baker Avenue Asset Management, LP | 54 | $981 | 0.00% |
| GWM Advisors LLC | 92 | $2 | 0.00% |
Sold out (12)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Caas Capital Management LP | 169,080 | $2.52M |
| UBS Oconnor LLC | 80,112 | $1.20M |
| Monashee Investment Management LLC | 60,000 | $895.0K |
| HRT Financial LP | 40,834 | $609.0K |
| Alps Advisors Inc | 21,409 | $319.0K |
| Mariner, LLC | 12,356 | $184.0K |
| Marshall Wace, LLP | 11,055 | $166.0K |
| Acuta Capital Partners, LLC | 10,000 | $149.0K |
| Seven Grand Managers, LLC | 10,000 | $149.0K |
| Gladius Capital Management LP | 3,686 | $55.0K |
| CarsonAllaria Wealth Management, Ltd. | 285 | $4.00K |
| Bogart Wealth, LLC | 40 | $1.00K |
Not filed for Q4 2022 yet (1)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wipfli Financial Advisors LLC, | 447 | $7.00K |